Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3-Reference-Cited by-同舟云学术

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3

Published:2012-05 Issue:3 Volume:16 Page:232-236
ISSN:1413-8670
Container-title:The Brazilian Journal of Infectious Diseases
language:en
Short-container-title:The Brazilian Journal of Infectious Diseases

Author:

Vigani Aline Gonzalez,Gonçales Eduardo Sellan,Postal Pavan Maria Helena,Genari Flavia,Tozzo Raquel,Kroll Lazarini Maria Silvia,Fais Viviane,Feltrin Adriana,Gonçales Neiva Sellan,Gonçales Fernando Lopes

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference18 articles.

1. Burden of liver disease in the United States: summary of a workshop;Kim;Hepatology,2002

2. Trends in health care resource use for hepatitis C virus infection in the United States;Grant;Hepatology,2005

3. Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels;Bini;Aliment Pharmacol Ther,2006

4. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C;Poynard;Gastroenterology,2002

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective;International Journal of Hepatology;2015

2. Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment;Brazilian Journal of Pharmaceutical Sciences;2014-04

3. Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis;The Brazilian Journal of Infectious Diseases;2013-09